Article
PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction: results from the Stockholm Heart Epidemiology Program (SHEEP).
Thrombosis and haemostasis - 1 Jun 2003
Leander Karin, Wiman Björn, Hallqvist Johan, Sten-Linder Margareta, de Faire Ulf
Abstract excerpt
This study examines the relationship between plasma Plasminogen Activator Inhibitor-1 (PAI-1) activity and the PAI-1 4G/5G polymorphism, and their association with the risk of myocardial infarction (MI). Furthermore, this study explores whether a high level of PAI-1 or whether the PAI-1 4G/5G polymorphism synergistically interacts with any established environmental risk factor for MI. This case-referent study of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
